Do you really think they would tell you or any of us if they are planning a tribute to Dr. Linda Liau that is being kept as big a surprise to the world as they can keep it until the journal article and top line data are released? The medical community has seen the focus on cell therapy change dramatically over the last 6-8 years and word is getting out fast now. The time is now and the British connection to the Lancet and influence of Dr. Ashkan tells me the MHRA GMP cert timing is in the bag for optimum impact. The recent PR was probably given to nervous investors to let them know. One of my friends and fellow NWBO investors was talking to one of his friends in the last 48 hours who had just been prepping at work to talk about the high cost of medical insurance to some in the insurance industry and that friend had just been informed about the potential of DCVax to have a positive impact on cancer treatment costs. That my friend knew about NWBO more than he did stopped the conversation in it’s tracks from surprise as this was all very new to him. We are the informed with regard to NWBO’s DCVax platform and soon the world will know that DCVax-L was created by Dr. Linda Liau and that it works. I hope Dr. Coley and others get honorable mention in the footnotes. Best wishes.
Market Data 
Markets 
AI
